Coronary Disease - Blood
Research News and Information

Monday, November 23, 2009

C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force.

4 Oct 2009 BACKGROUND: C-reactive protein (CRP) may help to refine global risk assessment for coronary heart disease (CHD), particularly among persons who are at intermediate risk on the basis of traditional risk factors alone. PURPOSE: To assist the U.S. ... Read more...

Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.

29 Sep 2009 BACKGROUND: Adrenoceptors mediate contraction of vascular smooth muscle and induce coronary vasoconstriction in humans. A deletion variant of the human alpha(2B)-adrenoreseptor of glutamic acid residues has been associated with impaired receptor ... Read more...

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.

29 Sep 2009 BACKGROUND: Residual cardiovascular (CV) risk often remains high despite statin therapy to lower low-density lipoprotein cholesterol (LDL-C). New therapies to raise high-density lipoprotein cholesterol (HDL-C) are currently being investigated. ... Read more...

Latest indexed articles for 'Coronary Disease - Blood'

These are the very latest articles for this heading:

• C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. 4 Oct 2009
• Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death. 29 Sep 2009
• Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. 29 Sep 2009
• Cardiovascular event risk: high-density lipoprotein and paraoxonase. 27 Sep 2009
• Risk factors: Lipoprotein(a) and coronary disease-moving closer to causality. 30 Aug 2009
• Invited commentary. 30 Aug 2009
• Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. 30 Aug 2009
• Progress in lipid nutrition: the Columbus Concept addressing chronic diseases. 15 Aug 2009
• Blood cholesterol as a good marker of health in Japan. 15 Aug 2009
• Dietary cholesterol and blood cholesterolemia: a healthy relationship. 15 Aug 2009
• Measuring blood fatty acids as a surrogate indicator for coronary heart disease risk in population studies. 15 Aug 2009
• Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. 9 Aug 2009
• APOE genotype, lipids, and coronary heart disease risk: a prospective population study. 8 Aug 2009
• N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study. 30 Jul 2009
• Protamine-associated hypotension in patients on hemodialysis: retrospective study and prevalence of antiprotamine antibodies. 30 Jul 2009
• Increases in serum concentration of human heart-type fatty acid-binding protein following elective coronary intervention. 30 Jul 2009
• C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. 30 Jul 2009
• Shellfish consumption and risk of coronary heart disease. 30 Jul 2009
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. 20 Jul 2009
• Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Coronary Disease'

Definition: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Descriptor UI: D003327

Alternative terms: Coronary Disease; Coronary Diseases; Disease, Coronary; Diseases, Coronary; Coronary Heart Disease; Coronary Heart Diseases; Disease, Coronary Heart; Diseases, Coronary Heart; Heart Disease, Coronary; Heart Diseases, Coronary;

Related Mesh Headings: Coronary Artery Bypass; Myocardial Revascularization; Angioplasty, Transluminal, Percutaneous Coronary;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C14.280.647.250; C14.907.585.250;

Technical Notes: general or unspecified; prefer specifics